◂ Announcements

Medical Devicesworld trade 2024+5.1% 5Y CAGR

Jan 17, 2020EXPANSIONToyama, Japan

Astellas to build ¥10B API manufacturing facility for Prograf in Toyama, Japan

Astellas Pharma announced the construction of a new manufacturing facility for the active pharmaceutical ingredient of Prograf at its Toyama Technology Center in Japan. The total construction cost is approximately ¥10.0 billion, with construction starting in April 2020 and completion scheduled for August 2021.

Value

$92.0M (10.0B JPY)

Starts operating

Aug 2021

Status

Announced

Capacity

7220 m2 total floor area

Productsactive pharmaceutical ingredient of Prograf (tacrolimus hydrate)

CompaniesAstellas Pharma Inc.Astellas Pharma Tech partner

Sectors#Medical Devices

“The purpose of the construction of the Third Fermentation Building is to enhance our production capacity that will enable a stable supply of high-quality products in the future.”newsroom.astellas.com

2 sources
newsroom.astellas.comGlobal News | AstellasJan 17, 2020
pharmafocusasia.comAstellas' New Pharma Manufacturing Facility in Japan | PharmaFocus AsiaFeb 28, 2020

Summarized from public sources; check the original articles before acting on it.

More from Astellas Pharma Inc.

profile ▸

Loading…